Steven Lo's Insider Trades & SAST Disclosures
Steven Lo's most recent trade in Edwards Lifesciences Corp was a trade of 5,739 Common Stock done at an average price of $45.3 . Disclosure was reported to the exchange on Feb. 14, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Steven Lo.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Edwards Lifesciences Corp | Steven R. Loranger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 45.32 per share. | 14 Feb 2025 | 5,739 | 66,111 (0%) | 0% | 45.3 | 260,073 | Common Stock |
| Edwards Lifesciences Corp | Steven R. Loranger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 5,739 | 0 | - | - | Director Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Steven R. Loranger | Director | Sale of securities on an exchange or to another person at price $ 76.42 per share. | 14 Feb 2025 | 5,739 | 60,372 (0%) | 0% | 76.4 | 438,576 | Common Stock |
| OmniAb Inc | Steven Love | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 13,333 | 46,667 | - | - | Restricted Stock Units | |
| OmniAb Inc | Steven Love | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 13,333 | 13,333 | - | - | Common Stock | |
| OmniAb Inc | Steven Love | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| OmniAb Inc | Steven Love | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 20,000 | 60,000 | - | - | Restricted Stock Units | |
| Zumiez Inc | Steven P. Louden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 4,655 | 18,071 (0%) | 0% | 0 | Common Stock | |
| TPI Composites Inc | Steven C. Lockard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 30,134 | 30,134 | - | - | Restricted Stock Units | |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2024 | 10,044 | 441,873 (1%) | 0% | 0 | Common Stock | |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2024 | 10,044 | 0 | - | - | Restricted Stock Units | |
| Edwards Lifesciences Corp | Steven R. Loranger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 3,055 | 59,373 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Steven R. Loranger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 999 | 60,372 (0%) | 0% | 0 | Common Stock | |
| Vaxart Inc | Steven Lo | Director, President, Chief Exec Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2024 | 1,000,000 | 1,000,000 | - | - | Stock Option (right to buy) | |
| Vaxart Inc | Steven Lo | Director, President, Chief Exec Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2024 | 250,000 | 250,000 (0%) | 0% | 0 | Common Stock | |
| Sunpower Corp | Steven Louden P. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2024 | 12,020 | 0 | - | - | Restricted Stock Units (RSUs) | |
| Sunpower Corp | P. Louden Steven | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2024 | 12,020 | 34,746 (0%) | 0% | 0 | Common Stock | |
| Sunpower Corp | Louden P. Steven | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 12,020 | 12,020 | - | - | Restricted Stock Units (RSUs) | |
| Sunpower Corp | P. Louden Steven | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2023 | 10,483 | 22,726 (0%) | 0% | 0 | Common Stock | |
| Sunpower Corp | Louden P. Steven | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2023 | 10,483 | 10,483 | - | - | Restricted Stock Units (RSUs) | |
| Sunpower Corp | Steven Louden P. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2023 | 10,483 | 0 | - | - | Restricted Stock Units (RSUs) | |
| Sunpower Corp | Steven P. Louden | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2023 | 6,143 | 12,243 (0%) | 0% | 0 | Common Stock | |
| Sunpower Corp | Steven P. Louden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2023 | 6,143 | 6,143 | - | - | Restricted Stock Units (RSUs) | |
| Sunpower Corp | Steven P. Louden | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2023 | 6,143 | 0 | - | - | Restricted Stock Units (RSUs) | |
| Zumiez Inc | Steven P. Louden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 5,600 | 13,416 (0%) | 0% | 0 | Common Stock | |
| TPI Composites Inc | Steven C. Lockard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 10,044 | 10,044 | - | - | Restricted Stock Units | |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2023 | 9,513 | 0 | - | - | Restricted Stock Units | |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2023 | 9,513 | 431,829 (1%) | 0% | 0 | Common Stock | |
| Xylem Inc | Steven R. Loranger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 1,580 | 13,818 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Steven R. Loranger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 2,803 | 55,420 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Steven R. Loranger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 898 | 56,318 (0%) | 0% | 0 | Common Stock | |
| Sunpower Corp | Steven P. Louden | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2023 | 6,100 | 0 | - | - | Restricted Stock Units (RSUs) | |
| Sunpower Corp | Steven P. Louden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 6,100 | 6,100 | - | - | Restricted Stock Units (RSUs) | |
| Sunpower Corp | Steven P. Louden | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2023 | 6,100 | 6,100 (0%) | 0% | 0 | Common Stock | |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2023 | 51,829 | 422,316 (1%) | 0% | 0 | Common Stock | |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2023 | 51,829 | 0 | - | - | Restricted Stock Units | |
| TPI Composites Inc | Steven C. Lockard | Director | Sale of securities on an exchange or to another person at price $ 18.47 per share. | 30 Aug 2022 | 139,072 | 370,487 (1%) | 0% | 18.5 | 2,569,272 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Aug 2022 | 3,000 | 509,559 (1%) | 0% | 0 | Common Stock | |
| TPI Composites Inc | Steven C. Lockard | Director | Sale of securities on an exchange or to another person at price $ 19.00 per share. | 30 Aug 2022 | 482 | 512,559 (1%) | 0% | 19 | 9,158 | Common Stock |
| Roku Inc - Ordinary Shares... | Steven P. Louden | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2022 | 145,730 | 145,730 | - | - | Employee Stock Option (right to buy) | |
| Roku Inc - Ordinary Shares... | Steven P. Louden | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2022 | 19,790 | 19,790 | - | - | Employee Stock Option (right to buy) | |
| Saratoga Investment Corp | Steven M. Looney | Director | Purchase of securities on an exchange or from another person at price $ 23.54 per share. | 02 Aug 2022 | 1,250 | 3,758 (0%) | 0% | 23.5 | 29,425 | Common Stock |
| Zumiez Inc | Steven P. Louden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 2,729 | 7,816 (0%) | 0% | 0 | Common Stock | |
| TPI Composites Inc | Steven C. Lockard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 9,513 | 9,513 | - | - | Restricted Stock Units | |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 May 2022 | 2,335 | 513,041 (1%) | 0% | 0 | Common Stock | |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 May 2022 | 2,335 | 0 | - | - | Restricted Stock Units | |
| Xylem Inc | Steven R. Loranger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 1,812 | 12,238 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Steven R. Loranger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2022 | 2,300 | 51,880 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Steven R. Loranger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2022 | 737 | 52,617 (0%) | 0% | 0 | Common Stock | |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2022 | 23,261 | 510,706 (1%) | 0% | 0 | Common Stock | |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2022 | 23,261 | 0 | - | - | Restricted Stock Units | |
| Xylem Inc | Steven R. Loranger | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2021 | 12,491 | 46,407 (0%) | 0% | 0 | Common Stock | |
| TPI Composites Inc | Steven C. Lockard | Director | Purchase of securities on an exchange or from another person at price $ 14.49 per share. | 15 Dec 2021 | 3,000 | 428,702 (1%) | 0% | 14.5 | 43,469 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 2,335 | 2,335 | - | - | Restricted Stock Units | |
| Xylem Inc | Steven R. Loranger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 1,328 | 22,293 (0%) | 0% | 0 | Common Stock | |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2021 | 158,593 | 66,537 | - | - | Stock Option (Right to Buy) | |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.87 per share. | 11 May 2021 | 158,593 | 584,295 (1%) | 0% | 10.9 | 1,724,255 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Sale of securities on an exchange or to another person at price $ 45.00 per share. | 11 May 2021 | 157,793 | 426,502 (1%) | 0% | 45.0 | 7,100,401 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2021 | 66,537 | 0 | - | - | Stock Option (Right to Buy) | |
| TPI Composites Inc | Steven C. Lockard | Director | Sale of securities on an exchange or to another person at price $ 43.20 per share. | 11 May 2021 | 66,537 | 425,702 (1%) | 0% | 43.2 | 2,874,272 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.87 per share. | 11 May 2021 | 66,537 | 492,239 (1%) | 0% | 10.9 | 723,404 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Sale of securities on an exchange or to another person at price $ 45.44 per share. | 11 May 2021 | 800 | 425,702 (1%) | 0% | 45.4 | 36,352 | Common Stock |
| Edwards Lifesciences Corp | Steven R. Loranger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2021 | 3,270 | 3,270 | - | - | Director Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Steven R. Loranger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2021 | 2,615 | 49,580 (0%) | 0% | 0 | Common Stock | |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2021 | 23,522 | 425,702 (1%) | 0% | 0 | Common Stock | |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2021 | 23,522 | 0 | - | - | Restricted Stock Units | |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Nov 2020 | 197,315 | 216,130 | - | - | Stock Option (Right to Buy) | |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.87 per share. | 30 Nov 2020 | 197,315 | 542,751 (1%) | 0% | 10.9 | 2,145,248 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Sale of securities on an exchange or to another person at price $ 39.97 per share. | 30 Nov 2020 | 120,208 | 422,543 (1%) | 0% | 40.0 | 4,805,086 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Sale of securities on an exchange or to another person at price $ 40.92 per share. | 30 Nov 2020 | 41,034 | 381,509 (1%) | 0% | 40.9 | 1,679,255 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Sale of securities on an exchange or to another person at price $ 41.70 per share. | 30 Nov 2020 | 36,073 | 345,436 (0%) | 0% | 41.7 | 1,504,132 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.87 per share. | 23 Nov 2020 | 111,065 | 456,501 (1%) | 0% | 10.9 | 1,207,521 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Nov 2020 | 111,065 | 413,445 | - | - | Stock Option (Right to Buy) | |
| TPI Composites Inc | Steven C. Lockard | Director | Sale of securities on an exchange or to another person at price $ 38.63 per share. | 23 Nov 2020 | 71,221 | 385,280 (1%) | 0% | 38.6 | 2,751,474 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Nov 2020 | 38,935 | 524,510 | - | - | Stock Option (Right to Buy) | |
| TPI Composites Inc | Steven C. Lockard | Director | Sale of securities on an exchange or to another person at price $ 40.25 per share. | 23 Nov 2020 | 38,935 | 345,436 (0%) | 0% | 40.3 | 1,567,286 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.87 per share. | 23 Nov 2020 | 38,935 | 384,371 (1%) | 0% | 10.9 | 423,309 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Sale of securities on an exchange or to another person at price $ 39.69 per share. | 23 Nov 2020 | 38,044 | 347,236 (0%) | 0% | 39.7 | 1,509,993 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Sale of securities on an exchange or to another person at price $ 40.23 per share. | 23 Nov 2020 | 1,800 | 345,436 (0%) | 0% | 40.2 | 72,408 | Common Stock |
| Edwards Lifesciences Corp | Steven R. Loranger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2020 | 19,797 | 0 | - | - | Director Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Steven R. Loranger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.20 per share. | 16 Nov 2020 | 19,797 | 46,965 (0%) | 0% | 35.2 | 696,789 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.87 per share. | 13 Nov 2020 | 103,166 | 448,602 (1%) | 0% | 10.9 | 1,121,641 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Nov 2020 | 103,166 | 612,964 | - | - | Stock Option (Right to Buy) | |
| TPI Composites Inc | Steven C. Lockard | Director | Sale of securities on an exchange or to another person at price $ 40.25 per share. | 13 Nov 2020 | 98,695 | 349,907 (0%) | 0% | 40.3 | 3,972,632 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Nov 2020 | 42,647 | 563,445 | - | - | Stock Option (Right to Buy) | |
| TPI Composites Inc | Steven C. Lockard | Director | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 13 Nov 2020 | 42,647 | 345,436 (0%) | 0% | 40 | 1,705,880 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.87 per share. | 13 Nov 2020 | 42,647 | 388,083 (1%) | 0% | 10.9 | 463,667 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Nov 2020 | 6,872 | 606,092 | - | - | Stock Option (Right to Buy) | |
| TPI Composites Inc | Steven C. Lockard | Director | Sale of securities on an exchange or to another person at price $ 40.11 per share. | 13 Nov 2020 | 6,872 | 345,436 (0%) | 0% | 40.1 | 275,618 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.87 per share. | 13 Nov 2020 | 6,872 | 352,308 (1%) | 0% | 10.9 | 74,714 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director | Sale of securities on an exchange or to another person at price $ 41.29 per share. | 13 Nov 2020 | 4,471 | 345,436 (0%) | 0% | 41.3 | 184,588 | Common Stock |
| Xylem Inc | Steven R. Loranger | Director | Sale of securities on an exchange or to another person at price $ 83.95 per share. | 11 Sep 2020 | 18,388 | 9,098 (0%) | 0% | 83.9 | 1,543,623 | Common Stock |
| TPI Composites Inc | Steven C. Lockard | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 18.23 per share. | 13 May 2020 | 5,000 | 345,436 (0%) | 0% | 18.2 | 91,150 | Common Stock |
| Xylem Inc | Steven R. Loranger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2020 | 2,577 | 20,965 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Steven R. Loranger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2020 | 1,378 | 1,378 | - | - | Director Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Steven R. Loranger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2020 | 1,101 | 9,056 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges